Literature DB >> 9186876

Influence of nycthemeral blood pressure pattern in treated hypertensive patients on hemodialysis.

J Amar1, I Vernier, E Rossignol, V Lenfant, J J Conte, B Chamontin.   

Abstract

Arterial hypertension in end-stage renal disease (ESRD) patients is characterized by an altered nycthemeral blood pressure (BP) rhythm and an increased pulse pressure, and it could be suggested that this association of risk factors plays a major role in the cardiovascular prognosis of this population. The aim of this study was to determine the influence of nycthemeral BP pattern on arterial distensibility and pulsatile components of BP in treated hypertensive patients on regular hemodialysis. Forty-two hypertensive patients were included, and all underwent ambulatory BP and pulse wave velocity (PWV) measurements between the femoral and carotid arteries. The patients were divided into two groups according to the magnitude of the nocturnal fall in BP: dippers and non-dippers. The groups were similar in gender, age, duration of hemodialysis, body mass index, body size, history of cardiovascular complications, class and number of antihypertensive drugs used per patient. PWV was significantly higher in non-dippers. For the whole population, a stepwise regression analysis showed that PWV and erythropoietin therapy were independently related to the impaired nycthemeral BP pattern. In addition to its pressor effect, erythropoietin could have a deleterious influence on the ambulatory BP profile of treated hypertensive patients in ESRD. Arterial distensibility and nycthemeral BP impairment are linked, and these cardiovascular risk factors should be taken into account together for the management of hypertensive hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186876     DOI: 10.1038/ki.1997.254

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2019-08-28       Impact factor: 3.455

2.  Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.

Authors:  Rajiv Agarwal; Arjun D Sinha; Maria K Pappas; Terri N Abraham; Getachew G Tegegne
Journal:  Nephrol Dial Transplant       Date:  2014-01-06       Impact factor: 5.992

3.  Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients.

Authors:  Francesca Viazzi; Giovanna Leoncini; Elena Ratto; Giulia Storace; Annalisa Gonnella; Debora Garneri; Barbara Bonino; Francesca Cappadona; Emanuele L Parodi; Daniela Verzola; Giacomo Garibotto; Roberto Pontremoli
Journal:  J Nephrol       Date:  2016-06-01       Impact factor: 3.902

Review 4.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

Review 5.  Optimal blood pressure level and best measurement procedure in hemodialysis patients.

Authors:  Annie Saint-Remy; Jean-Marie Krzesinski
Journal:  Vasc Health Risk Manag       Date:  2005
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.